PRP Maintenance Schedules: Induction, Boosters and Honest Expectations

On this page
"How often?" is the question every PRP consultation ends with, and too many clinics answer it with whatever the diary needs that quarter. There is no single PRP maintenance schedule hair clinics can copy off a shelf — the trials tested induction courses, not long-term maintenance — but the shape of a defensible programme is well established: a measured induction, an honest review, then spaced boosters for the patients who demonstrably respond. Everything else in this piece is the operational detail that makes that shape hold.
The underlying biology is unglamorous. PRP does not switch off androgenetic alopecia; it appears to push follicles towards anagen and thicken what remains, and the effect decays once sessions stop. Maintenance is therefore legitimate — and open-ended. Patients deserve both halves of that sentence before the first blood draw, because the second half is what they are actually buying.
Why maintenance exists at all
The trial base is an induction base. Gentile and colleagues treated monthly for three sessions and measured at three and six months; Alves and Grimalt ran the same rhythm in a half-head design. Both showed hair-count gains over placebo. Neither followed patients for years on boosters, and no controlled trial has settled the optimal maintenance interval.
That leaves a clean evidence gradient: the induction phase is trial-anchored, the review gate is measurement, and the booster interval is practice convention. Design the programme accordingly — make confident claims about the first ninety days, and present everything after month six as a titrated plan the patient co-owns. Clinics get into trouble when they invert this, mumbling through induction and speaking with false precision about year two.
The decay itself is predictable enough to plan around. Responders who stop treatment typically drift back towards their untreated trajectory over six to twelve months. That number does two jobs: it justifies boosters for responders, and it defines the honest answer when a satisfied patient asks what happens if they walk away.
The induction phase sets up everything
Run induction as three sessions at four-week intervals, with a fourth only where a specific reason exists. PRP session frequency during induction is the settled part of the whole schedule: four weeks apart is close enough to stack biological effect and far enough apart to schedule around real lives. The session mechanics — draw volumes, spin, injection mapping — are covered in our step-by-step PRP protocol and are not the failure point.
The failure point is measurement. Baseline must be captured before the first needle: six standardised photographic views with fixed camera, lighting, angle and parting, plus trichoscopic density at a repeatable landmark point if you have the kit. Without that baseline the month-six review becomes an exchange of impressions, and impressions always favour continuing. Twenty minutes of photography protects both parties from a year of ambiguity.
Induction is also where the medication conversation belongs. Finasteride carries controlled data back to the 1990s; PRP rides alongside it, not instead of it. Document the offer and the patient's decision either way — the patients most insistent on skipping medication are the ones to photograph most carefully.
A PRP maintenance schedule hair clinics can defend
| Phase | Timing | Purpose | Exit rule |
|---|---|---|---|
| Induction | 3 sessions, 4-week intervals | Establish biological response | Completed in full before any judgement |
| Review gate | Month 6 from first session | Objective comparison against baseline | No measurable change — stop or switch |
| Maintenance | Single booster every 3–6 months | Hold gains in documented responders | Re-photograph annually; stop if gains hold without it |
| Relapse response | One booster plus review | Catch early regression between boosters | Persistent regression — rediscuss medication |
The table's most important column is the last one. A schedule without exit rules is a subscription, and patients eventually notice the difference. The review gate needs teeth: if month-six photographs and trichoscopy show nothing, the clinic stops, switches the plan — some patients do better moving to or adding mesotherapy or medical therapy — or refers onward. Keeping non-responders on boosters is the most expensive revenue a clinic can earn; it converts one quiet refund into a public trust problem.
Note what the schedule does not contain: a monthly maintenance tier. The common belief that more frequent boosters must hold gains better has no controlled support, and the trial protocols it claims descent from were monthly induction courses, not standing orders. Monthly-forever is a cash-flow model wearing clinical dress.
Choosing booster intervals patient by patient
How often PRP for hair needs repeating is a per-patient answer inside a narrow band, and the band is three to six months.
| Interval model | Sessions per year | Best suited to | Failure mode |
|---|---|---|---|
| Quarterly booster | 4 | Non-medicated patients, early shedding recurrence | Cost fatigue by year two |
| 4–6 month booster | 2–3 | Stable responders on finasteride or minoxidil | Drift and missed appointments |
| Monthly ongoing | 12 | Almost nobody | Revenue optics, patient burnout, no evidence |
| On-demand only | 0–2 | Patients who refuse structure | Relapse discovered late |
Titrate with two variables: medication status and shedding history. A patient on finasteride with stable photographs earns the six-month end; a medication-decliner with early recurrence sits at three. Booster pricing is where a PRP booster hair loss plan either builds trust or burns it — the annual plan with two to four sessions and a built-in review reads as clinical care, while an open-ended monthly charge reads as a gym membership, and patients cancel it like one.
Running maintenance as an operation
Most PRP programmes fail in the diary, not the syringe. The clinical work is 45 minutes a session; the operational work is making sure the session happens at month nine, and that is a recall system, not a medical skill.
The mechanics are unglamorous and effective: the next booster is booked before the patient leaves the building; reminders go at four weeks and two weeks; a lapsed patient gets one personal call within a fortnight of the missed date. Give the whole loop a named owner — in most clinics this sits naturally with the coordinator role described in our piece on the patient coordinator — and report attendance monthly alongside revenue. A PRP maintenance schedule hair patients actually keep is one the diary enforces, not one the leaflet describes.
Annual plans do the financial half of the same job. Bundle induction with the month-six review at one price, then offer a maintenance year covering the boosters and the annual photography. Clinics building this from scratch can borrow structure from clinic-facing curricula — Bind Pharma publishes worked protocol and programme material — but the review gates and stopping rules only work if your own team owns them locally. The wider commercial design of the service line is covered in building a PRP programme.
Honest expectations are the retention strategy
The instinct is to soften the pitch: talk about growth, skip the decay, let year two take care of itself. It reads as kindness and performs as churn. The patients who stay for years are the ones told at the start that PRP is maintenance therapy, that month six is a genuine checkpoint with a real possibility of stopping, and that photographs — not moods — make the call.
Set three expectations in the first consultation and put them in writing: visible change is judged at month six, not week four; gains fade over six to twelve months if maintenance stops; and the clinic will recommend stopping if the pictures do not move. The third promise is the counterintuitive one, and it is the one that gets quoted in reviews. A stopping rule, published and occasionally used, sells more maintenance plans than any discount ever has.
Sources and further reading
- Gentile P, Garcovich S, Bielli A, et al. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Translational Medicine. 2015;4(11):1317–1323.
- Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatologic Surgery. 2016;42(4):491–497.
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4 Pt 1):578–589.
Frequently asked questions
What induction schedule do most clinics run before maintenance?
Three sessions at four-week intervals is the dominant pattern, and it matches the randomised trials that underpin PRP for androgenetic alopecia — Gentile's group and Alves and Grimalt both treated monthly for three sessions. Some clinics run four. Going beyond four sessions before any formal review adds cost without adding decision-relevant information for either side.
How often should PRP boosters be given after induction?
Every three to six months for patients with documented response. Start at three months where shedding recurs early or the patient declines medical therapy; stretch towards six for stable responders on finasteride or minoxidil. The interval is titrated to each patient's photographed trajectory within that band — it is not fixed by the price list.
When will patients see results, and what should we tell them?
Tell them shedding can briefly increase in the first weeks, visible change is realistic from month three, and judgement happens at month six with photographs rather than mirrors. Promising visible density at four weeks sets the programme up to fail — the follicle cycle does not move that fast, and patients remember exactly what they were told at the first consultation.
What counts as a response worth maintaining?
A visible difference between standardised baseline and month-six photographs taken with the same camera, lighting, angle and parting, ideally supported by trichoscopic density at a fixed landmark point, plus the patient's own shedding report. If neither photographs nor trichoscopy show change, a subjective "feels thicker" should not by itself trigger a year of boosters.
Should patients stop finasteride or minoxidil once PRP starts?
No. PRP does not address the androgen mechanism, and the finasteride evidence base is deeper than PRP's by two decades. The cleanest framing is PRP as an adjunct for motivated patients or an alternative for those who decline or cannot tolerate medication. Combined patients are also the ones who can usually stretch boosters towards the six-month end.
What happens if a patient simply stops maintenance?
The androgenetic process resumes and gained density erodes, typically over six to twelve months, back towards the untreated trajectory. That is not a scare line; it is the honest description of a maintenance therapy, and it belongs in the first consultation — not discovered on a forum eighteen months after the patient stopped attending.
Are monthly ongoing PRP schedules ever justified?
Rarely, and never by the trial data — the published protocols were monthly induction, not monthly forever, and no controlled evidence shows monthly maintenance beating quarterly boosters. A clinic quoting indefinite monthly sessions is describing its cash-flow model. Exceptions belong inside supervised protocols with documented reasoning, as exceptions with notes rather than defaults.
How should PRP maintenance be priced?
As a plan with the review built in: induction plus the month-six photographic review bundled at a single price, then an annual maintenance plan covering two to four boosters. Plans align the patient with attendance and the clinic with demonstrating results at each gate. Per-session pricing invites drift, and drift quietly kills both adherence and outcomes.
What recall system actually keeps maintenance patients?
A named owner. Book the next booster before the patient leaves the building, run reminders at four weeks and two weeks before the date, and place one phone call for lapsed patients within a fortnight. Clinics that leave recall to patient initiative lose a large share of the maintenance base within a year — and then blame the therapy.
The Hair Transplant Source editorial team produces independent, technique-level reference material for hair restoration clinicians and clinic operators. Articles are written by the team and, where the topic is clinical, reviewed by a named hair restoration surgeon before they are presented as reviewed clinical content.
- Independent editorial line
- Clinical articles reviewed by named surgeons
- No paid editorial coverage
Related reading



